Echelon Biosciences
biotinylated anti ptdins Biotinylated Anti Ptdins, supplied by Echelon Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/biotinylated anti ptdins/product/Echelon Biosciences Average 93 stars, based on 1 article reviews Price from $9.99 to $1999.99
biotinylated anti ptdins - by Bioz Stars,
2023-03
93/100 stars
|
Buy from Supplier |
Echelon Biosciences
biotin pip3 ![]() Biotin Pip3, supplied by Echelon Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/biotin pip3/product/Echelon Biosciences Average 86 stars, based on 1 article reviews Price from $9.99 to $1999.99
biotin pip3 - by Bioz Stars,
2023-03
86/100 stars
|
Buy from Supplier |
Image Search Results

Journal:
Article Title: Foxo3 is a PI3K-Dependent Molecular Switch Controlling the Initiation of Oocyte Growth
doi: 10.1016/j.ydbio.2008.06.017
Figure Lengend Snippet: Pten regulates primordial follicle activation via PI3K and Foxo3. Pten ablation leads to increased PIP3, Akt activation, Foxo3 hyperphosphorylation, and nuclear export. Panels show Pten, PIP3, p-Akt (Ser473), Foxo3 and p-Foxo3 (Thr32) in PD3 ovaries counterstained with hematoxylin or DAPI (PIP3).
Article Snippet: Frozen sections (5μ) were obtained and detection of PIP3 was performed as described ( Kitamura et al., 2004 ) with
Techniques: Activation Assay
![Model of Foxo3 regulation by PI3K-Akt signaling pathway within oocytes in the control of primordial follicle activation. In resting state, absence of a presumptive ligand engaging receptor tyrosine kinase (RTK) complex or other cell surface receptor is associated with diminished Akt signalling in primordial oocytes. Foxo3 is unphosphorylated and thus localized to the nucleus, where Foxo3 acts to suppresses primordial follicle activation. Binding of presumptive ligand activates PI3K (consisting of p85 regulatory and p110 catalytic subunits), which phosphorylates the 3’OH group of PI[4,5]P2 (PIP2) to form PI[3,4,5]P3 (PIP3) at the oocyte membrane. Pten acts as a potent negative regulator of this pathway by dephosphorylating PIP3. Pten inactivation results in accumulation of PIP3 at the oocyte membrane and hyperactivation of Akt, resulting in Foxo3 phosphorylation and nuclear export, thereby triggering primordial follicle activation. In this model, Pten inactivation is functionally equivalent to the binding of presumptative ligand at a cell surface receptor.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_8299/pmc02548299/pmc02548299__nihms67577f7.jpg)
Journal:
Article Title: Foxo3 is a PI3K-Dependent Molecular Switch Controlling the Initiation of Oocyte Growth
doi: 10.1016/j.ydbio.2008.06.017
Figure Lengend Snippet: Model of Foxo3 regulation by PI3K-Akt signaling pathway within oocytes in the control of primordial follicle activation. In resting state, absence of a presumptive ligand engaging receptor tyrosine kinase (RTK) complex or other cell surface receptor is associated with diminished Akt signalling in primordial oocytes. Foxo3 is unphosphorylated and thus localized to the nucleus, where Foxo3 acts to suppresses primordial follicle activation. Binding of presumptive ligand activates PI3K (consisting of p85 regulatory and p110 catalytic subunits), which phosphorylates the 3’OH group of PI[4,5]P2 (PIP2) to form PI[3,4,5]P3 (PIP3) at the oocyte membrane. Pten acts as a potent negative regulator of this pathway by dephosphorylating PIP3. Pten inactivation results in accumulation of PIP3 at the oocyte membrane and hyperactivation of Akt, resulting in Foxo3 phosphorylation and nuclear export, thereby triggering primordial follicle activation. In this model, Pten inactivation is functionally equivalent to the binding of presumptative ligand at a cell surface receptor.
Article Snippet: Frozen sections (5μ) were obtained and detection of PIP3 was performed as described ( Kitamura et al., 2004 ) with
Techniques: Activation Assay, Cell Surface Receptor Assay, Binding Assay